Your browser doesn't support javascript.
loading
ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC.
Vokes, Natalie I; Galan Cobo, Ana; Fernandez-Chas, Margarita; Molkentine, David; Treviño, Santiago; Druker, Vitaly; Qian, Yu; Patel, Sonia; Schmidt, Stephanie; Hong, Lingzhi; Lewis, Jeff; Rinsurongkawong, Waree; Rinsurongkawong, Vadeerat; Lee, J Jack; Negrao, Marcelo V; Gibbons, Don L; Vaporciyan, Ara; Le, Xiuning; Wu, Jia; Zhang, Jianjun; Rigney, Una; Iyer, Sonia; Dean, Emma; Heymach, John V.
Affiliation
  • Vokes NI; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Galan Cobo A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fernandez-Chas M; Department of Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Molkentine D; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
  • Treviño S; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Druker V; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Qian Y; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
  • Patel S; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Schmidt S; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hong L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lewis J; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rinsurongkawong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rinsurongkawong V; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Negrao MV; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gibbons DL; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vaporciyan A; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Le X; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu J; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang J; Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Rigney U; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Iyer S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dean E; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
  • Heymach JV; Oncology R&D, AstraZeneca, Cambridge, United Kingdom.
Clin Cancer Res ; 29(23): 4958-4972, 2023 12 01.
Article in En | MEDLINE | ID: mdl-37733794
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ataxia Telangiectasia / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ataxia Telangiectasia / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: Estados Unidos